Ocular Therapeutix, Inc. (OCUL)
10.76
-0.22
(-2.00%)
USD |
NASDAQ |
Mar 03, 16:00
10.67
-0.09
(-0.84%)
After-Hours: 20:00
Ocular Therapeutix Research and Development Expense (Annual) : 197.10M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Abbott Laboratories | 2.889B |
| EyePoint Plc | 132.93M |
| Quince Therapeutics, Inc. | 18.59M |
| Ernexa Therapeutics, Inc. | 4.604M |